DOI: 10.1111/apt.14270 , PMID: 28815645 Issn Print: 0269-2813 Publication Date: 2017/10/01 Print Facebook Twitter LinkedIn Email Lenalidomide as second‐line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy Y.‐Y. Shao; B.‐B. Chen; D.‐L. Ou; Z.‐Z. Lin; C.‐H. Hsu; M.‐J. Wang; A.‐L. Cheng; C. Hsu + Author Information Author Information: Graduate Institute of Oncology Checking for direct PDF access through Ovid View on Journal Site Abstract Abstract unavailable for this article.